Planning project: EIC Accelerator - Large-Scale Atlasing for Precision Medicine
| Reference number | |
| Coordinator | Precisiumai AB |
| Funding from Vinnova | SEK 300 000 |
| Project duration | July 2025 - May 2026 |
| Status | Completed |
| Venture | Global cooperation 2025 |
| Call | Planning grant for international proposal 2025 |
Important results from the project
Yes, the project met its main goals across all work packages, including market validation, benchmarking, IP strategy, financial planning, and a complete EIC application. We also secured 23 letters of intent. Additional results include new biotech partnerships, validation of data commercialization opportunities, and collaboration with an IP firm that strengthened our FTO position and future patent strategy.
Expected long term effects
The project strengthens our market position through validated benchmarks, clear competitive positioning, and defined USPs. It improves operational maturity via structured processes and policies, and secures long-term competitive advantage through formalized trade secret protection and IP strategy. These outcomes support future funding, commercialization, and scalable growth.
Approach and implementation
The project was structured into three work packages: WP1 focused on market analysis, benchmarking, and risk assessment; WP2 on IP strategy, TRL planning, and financial projections; WP3 on preparing the EIC application. Activities were executed sequentially with iterative refinement, integrating results into a full funding application and preparing for follow-up steps.